Frank Gentile
Oprichter bij Casma Therapeutics, Inc.
Profiel
Dr. Frank T.
Gentile is a Chief Executive Officer & Director at Casma Therapeutics, Inc. and a Venture Partner at Third Rock Ventures LLC.
He is on the Board of Directors at Casma Therapeutics, Inc. and Raven Biotechnologies, Inc.
Dr. Gentile was previously employed as a Senior Vice President by Tekla Capital Management LLC, a Vice President-Technology Program Management by Takeda Oncology Co., a Research Analyst by Millennium TVP Management Co. LLC, a Vice President-Program Management by Reprogenesis, Inc., a Vice President-Product Development by Curis, Inc., and a Principal by CytoTherapuetics, Inc. He also served on the board at FlowCardia, Inc., CardioKinetix, Inc., Conor Medsystems LLC, Euthymics Bioscience, Inc., Insightra Medical, Inc., Neurovance, Inc. and Veniti, Inc.
He received his undergraduate degree from the The Cooper Union for the Advancement of Science & Art and a doctorate degree from Massachusetts Institute of Technology.
Actieve functies van Frank Gentile
| Bedrijven | Functie | Begin |
|---|---|---|
Raven Biotechnologies, Inc.
 Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | Directeur/Bestuurslid | - |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01-01-2015 |
Casma Therapeutics, Inc.
 Casma Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Casma Therapeutics, Inc. operates biotechnology company harnessing natural cellular process of autophagy to design new medicines. The company was founded by Cary Pfeffer and is headquartered in Cambridge, MA. | Oprichter | 01-05-2018 |
Eerdere bekende functies van Frank Gentile
| Bedrijven | Functie | Einde |
|---|---|---|
Conor Medsystems LLC
 Conor Medsystems LLC Medical SpecialtiesHealth Technology Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA. | Directeur/Bestuurslid | 23-03-2005 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 31-12-2001 |
Millennium TVP Management Co. LLC
 Millennium TVP Management Co. LLC Investment ManagersFinance Millennium TVP Management Co LLC (Millennium TVP Mgmt) is a private equity firm founded in 1996 by Samuel Schwerin and Dan Burstein. The firm is headquartered in New York. | Private Equity Analist | 30-06-2001 |
| CURIS, INC. | Corporate Officer/Principal | 01-02-2001 |
Reprogenesis, Inc.
 Reprogenesis, Inc. BiotechnologyHealth Technology Reprogenesis, Inc., located in Cambridge, Massachusetts developes tissue engineered therapies to treat unmet medical needs. The Company has proprietary technology utilizing the combination of cells and biomaterials to restore, repair or replace lost tissue or physiological function. The Company has a broad preclinical and clinical pipeline of products in the areas of urology, cardiovascular biology and plastic and reconstructive surgery. ChondrogelTM is its most advanced product | Corporate Officer/Principal | 30-11-2000 |
Opleiding van Frank Gentile
| Massachusetts Institute of Technology | Doctorate Degree |
| The Cooper Union for the Advancement of Science & Art | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CURIS, INC. | Health Technology |
| Bedrijven in privébezit | 15 |
|---|---|
Tekla Capital Management LLC
 Tekla Capital Management LLC Investment ManagersFinance Tekla Capital Management LLC is an independent, SEC-registered investment advisor headquartered in Boston, Massachusetts. Formerly known as Hambrecht & Quist Capital Management LLC, the firm serves as an investment adviser for four closed-end funds – Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund. | Finance |
CardioKinetix, Inc.
 CardioKinetix, Inc. Medical SpecialtiesHealth Technology CardioKinetix, Inc. develops ventricular partitioning device for heart failure disease. It develops transcatheter implant called the Parachute Ventricular Partitioning Device, which intends to treat heart failure resulting from a heart attack in patients by improving overall cardiac function. The company was founded by Alexander Khairkhahan, Serjan D. Nikolic and Hugh R. Sharkey in 2002 and is headquartered in Menlo Park, CA. | Health Technology |
Conor Medsystems LLC
Conor Medsystems LLC Medical SpecialtiesHealth Technology Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Reprogenesis, Inc.
Reprogenesis, Inc. BiotechnologyHealth Technology Reprogenesis, Inc., located in Cambridge, Massachusetts developes tissue engineered therapies to treat unmet medical needs. The Company has proprietary technology utilizing the combination of cells and biomaterials to restore, repair or replace lost tissue or physiological function. The Company has a broad preclinical and clinical pipeline of products in the areas of urology, cardiovascular biology and plastic and reconstructive surgery. ChondrogelTM is its most advanced product | Health Technology |
| CytoTherapuetics, Inc. | Finance |
FlowCardia, Inc.
 FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Health Technology |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | Commercial Services |
Millennium TVP Management Co. LLC
Millennium TVP Management Co. LLC Investment ManagersFinance Millennium TVP Management Co LLC (Millennium TVP Mgmt) is a private equity firm founded in 1996 by Samuel Schwerin and Dan Burstein. The firm is headquartered in New York. | Finance |
Veniti, Inc.
 Veniti, Inc. Medical SpecialtiesHealth Technology Veniti, Inc. operates as a medical device company which focuses on the treatment of venous insufficiency. Its products include VENI RF Plus which uses radio frequency generated steam to destroy problematic veins that manifest as varicose veins; VENI Vena Cava Filter system which is engineered to improve the accuracy, efficiency of deployment, placement and retrieval; and VICI Venous Stent which is designed specifically for the treatment of venous outflow obstruction. The company was founded by Sean C. Morris and Mark Klopp in 2009 and is headquartered in Fremont, CA. | Health Technology |
Euthymics Bioscience, Inc.
 Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Commercial Services |
Neurovance, Inc.
 Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Commercial Services |
Insightra Medical, Inc.
 Insightra Medical, Inc. Medical SpecialtiesHealth Technology Insightra Medical, Inc. develops medical devices. It offers QuickWIT, a cardiology wire insertion tool, sensiPull, an ergonomic aortic punch, and the Modulare, a catheter stabilization device. The firm also offers innovative solutions for the common disease of inguinal hernias and ventral hernia. The company was founded by Bradley J. Sharp in March 2001 and is headquartered in Irvine, CA. | Health Technology |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Finance |
Casma Therapeutics, Inc.
Casma Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Casma Therapeutics, Inc. operates biotechnology company harnessing natural cellular process of autophagy to design new medicines. The company was founded by Cary Pfeffer and is headquartered in Cambridge, MA. | Commercial Services |
